糖尿病控制与治疗是否与8年间衰弱指数变化相关:来自Look AHEAD试验的辅助探索性研究
该研究基于Look AHEAD随机对照试验中4,169名45-76岁参与者,探索性分析HbA1c水平及降糖策略与衰弱指数(FI)基线水平及8年变化的关系。结果显示基线及平均HbA1c<7%较≥8%与FI评分增加较少相关(均P≤0.002);调整HbA1c后,使用二甲双胍和体重减轻>5%与衰弱增加较慢独立相关。
要点
- 基线及平均HbA1c<7%较≥8%与8年间FI评分增加较少相关(均P≤0.002)。
- 调整HbA1c后,使用二甲双胍与FI增加较慢独立相关。
- 调整HbA1c后,体重减轻>5%与FI增加较慢独立相关。
核心结论
- 糖尿病患者较低的HbA1c水平与以缺陷累积衰弱指数捕获的较慢生物学衰老相关。
- 通过体重减轻或使用二甲双胍控制糖尿病的策略也可能减缓衰老。
研究设计与样本
- 研究为Look AHEAD随机对照临床试验的探索性分析,纳入4,169名45-76岁参与者,随访8年,合并干预组数据。
- 采用方差分析和协方差分析评估HbA1c与FI的关联,并使用逆概率加权评估差异随访偏倚。
主要发现
- 基线及随时间平均HbA1c<7%较≥8%与8年间FI评分增加较少相关(均P≤0.002)。
- 调整HbA1c后,使用二甲双胍和体重减轻>5%均与衰弱增加较慢独立相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of this study was to describe cross-sectional and longitudinal associations between glycated hemoglobin (HbA1c) levels and strategies to control type 2 diabetes with baseline levels and 8-year changes in a deficit accumulation frailty index (FI), a commonly used marker of biological aging. RESEARCH DESIGN AND METHODS: We conducted exploratory analyses from 4,169 participants, aged 45-76 years, who were followed in the Action for Health in Diabetes (Look AHEAD) randomized controlled clinical trial, pooling data across intervention groups. We related baseline and 8-year levels of HbA1c with FI scores using analyses of variance and covariance. Associations between 8-year changes in FI and the use of diabetes medication classes and weight changes were assessed with control for HbA1c levels. Inverse probability weighting was used to assess bias associated with differential follow-up. RESULTS: Baseline and average HbA1c levels over time of <7%, as compared with ≥8%, were associated with less increase in FI scores over 8 years (both P ≤ 0.002). After adjustment for HbA1c, use of metformin and weight loss >5% were independently associated with slower increases in frailty. CONCLUSIONS: Lower HbA1c levels among individuals with diabetes are associated with slower biological aging as captured by a deficit accumulation FI. Strategies to control diabetes through weight loss or metformin use may also slow aging.
引用
- Simpson FR, Justice JN, Pilla SJ, et al. An Examination of Whether Diabetes Control and Treatments Are Associated With Change in Frailty Index Across 8 Years: An Ancillary Exploratory Study From the Action for Health in Diabetes (Look AHEAD) Trial. Diabetes Care. 2023. PMID: 36542537. doi:10.2337/dc22-1728
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。